رجوع
نطاق اليوم
KWD 1.86
KWD 2.00
نطاق 52 أسبوعًا
KWD 0.46
KWD 7.13
حجم التداول
804,092
متوسط 50 يوم / 200 يوم
KWD 2.16
/
KWD 2.35
الإغلاق السابق
KWD 1.93
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -3.7 | 0.4 |
| P/B | 1.9 | 2.9 |
| ROE % | — | 3.8 |
| Net Margin % | -16977.8 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
النقاط الرئيسية
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -135.31M
PEG of 0.11 suggests growth is underpriced
Capital intensive — 1701.68% of revenue goes to capex
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)1075.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
N/A
ROIC-40.74%
Net Margin-16977.83%
Op. Margin-18477.83%
الأمان
Debt / Equity
0.01
Current Ratio9.13
Interest Coverage-41251.75
التقييم
P/E Ratio
-3.70
P/B Ratio1.87
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1075.00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 893,000.0 | Net Income (TTM) | -151.61M |
| ROE | N/A | ROA | -45.18% |
| Gross Margin | -540.76% | Operating Margin | -18477.83% |
| Net Margin | -16977.83% | Free Cash Flow (TTM) | -135.31M |
| ROIC | -40.74% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 9.13 |
| Interest Coverage | -41251.75 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.70 | P/B Ratio | 1.87 |
| P/S Ratio | 628.96 | PEG Ratio | 0.11 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 561.66M | Enterprise Value | 456.09M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 893,000.0 | 76,000.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -151.61M | -61.19M | -35.47M | -108.03M | -55.15M |
| EPS (Diluted) | -0.51 | -0.62 | -0.57 | -1.76 | -1.73 |
| Gross Profit | -4.83M | 76,000.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -165.01M | -183.68M | -151.52M | -153.01M | -55.11M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 335.57M | 441.07M | 420.55M | 518.00M | 40.30M |
| Total Liabilities | 34.78M | 39.44M | 29.22M | 13.06M | 13.38M |
| Shareholders' Equity | 300.79M | -994.95M | -1.10B | -1.10B | 26.92M |
| Total Debt | 2.97M | 3.24M | 4.41M | 2.40M | 1.33M |
| Cash & Equivalents | 108.54M | 99.12M | 60.65M | 490.25M | 20.56M |
| Current Assets | 280.68M | 395.88M | 374.15M | 504.72M | 27.27M |
| Current Liabilities | 30.74M | 36.22M | 25.04M | 10.87M | 12.31M |